[关键词]
[摘要]
目的 对柴胡皂苷A进行体外生物转化,分析其体外代谢产物。方法 用人工胃液模拟胃酸环境,厌氧状态下与大鼠肠内容物共温孵模拟肠道环境,分别进行柴胡皂苷A的体外生物转化,采用HPLC-DAD-MSn方法,分析鉴定代谢产物。结果 在人工胃液中,柴胡皂苷A可转化为柴胡皂苷b1、柴胡皂苷g,在肠道菌群环境下,柴胡皂苷A可先转化为柴胡次皂苷F,进一步转化为柴胡皂苷元F。结论 模拟体内环境,柴胡皂苷A可转化成其次生苷和苷元,采用HPLC-DAD-MSn可以指认并鉴定其产物。柴胡皂苷A的药物分布与浓度不能全面反映其体内过程,应同时考察其次生代谢产物。
[Key word]
[Abstract]
Objective To study the biotransformation of saikosaponin A in vitro and analyze its metabolites. Methods Saikosaponin A was incubated in artificial gastric juice and intestinal contents of rats in anaerobic conditions, respectively, and the metabolites were analyzed and identified by HPLC-DAD-MSn. Results By incubation of saikosaponin A in artificial gastric juice, saikosaponin b1 and g were detected in the reaction mixture. By the anaerobic incubation of saikosaponin A with intestinal flora, prosaikogenin F was soon detected, but it was further converted to saikogenin F. Conclusion Saikosaponin A can be transformed to secondary glycosides and glycosides in artificial gastrointestinal environment. And the products can be identified by HPLC-DAD-MSn. The distribution and concentration of saikosaponin A in vivo can not reflect its fate fully, and the metabolites should be considered simutaneously.
[中图分类号]
[基金项目]
山东省自然科学基金重点项目(2011ZRB14333);山东省泰山学者工程专项经费资助(ts201511107)